Journal Home
Search for

Volume 67, Issue 2, Pages 101-109 (15 January 2010)


View previous. 9 of 27 View next.

Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression

Portions of this work were presented at the Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, Arizona, in December 2008.

Ziad NahasabCorresponding Author Informationemail address, Berry S. Andersona, Jeff Borckardtac, Ashley B. Aranaa, Mark S. Georgeabef, Scott T. Reevesc, Istvan Takacsbd

Received 12 June 2009; received in revised form 5 August 2009; accepted 11 August 2009. published online 12 October 2009.

Background

Treatment-resistant depression presents a serious challenge to both patients and clinicians. The anterior and midlateral prefrontal cortices play complementary roles in integrating emotional and cognitive experiences and in modulating subcortical regions. Both regions offer a distinct opportunity for targeted antidepressant treatments. We chose to pilot the safety and therapeutic benefits of chronic and intermittent epidural prefrontal cortical stimulation (EpCS) in patients with treatment-resistant depression.

Methods

We enrolled five adults with an average of 5.8 failed antidepressant treatments in their current depressive episode. All subjects underwent comprehensive clinical assessments, detailed neuropsychological testing, and presurgical magnetic resonance imaging. Four cortical stimulation paddle leads were stereotactically placed bilaterally over the anterior frontal poles and midlateral prefrontal cortex. We also acquired a postsurgical computed tomography scan and repeatedly assessed clinical outcomes over time of EpCS as an adjunctive treatment to constant medications.

Results

All patients tolerated the therapy. At 7-month follow-up, the average improvement from preimplant baseline on the Hamilton Rating Scale for Depression and the Inventory of Depressive Symptoms—Self-Report were 54.9% (± 37.7) and 60.1% (± 34.1), respectively. Three implanted subjects reached remission. One patient's left hemisphere leads were explanted 12 weeks postsurgery because of a scalp infection.

Conclusions

Bilateral EpCS over anterior and midlateral frontal cortex is a promising new technology for treatment-resistant depression. Future double-blind studies are warranted.

a Department of Psychiatry, Mood Disorders Program and Brain Stimulation Laboratory, Medical University of South Carolina, Charleston, South Carolina

b Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina

c Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina, Charleston, South Carolina

d Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina

e Department of Radiology, Medical University of South Carolina, Charleston, South Carolina

f Ralph H. Johnson VA Medical Center, Charleston, South Carolina

Corresponding Author InformationAddress correspondence to Ziad Nahas, M.D., M.S.C.R., Institute of Psychiatry, 67 President Street, Charleston, SC 29425

PII: S0006-3223(09)01020-8

doi:10.1016/j.biopsych.2009.08.021


View previous. 9 of 27 View next.